147 related articles for article (PubMed ID: 10584879)
21. Cyclin D1 A870G polymorphism and amplification in laryngeal squamous cell carcinoma: implications of tumor localization and tobacco exposure.
Monteiro E; Varzim G; Pires AM; Teixeira M; Lopes C
Cancer Detect Prev; 2004; 28(4):237-43. PubMed ID: 15350626
[TBL] [Abstract][Full Text] [Related]
22. Cyclin D1 overexpression in colorectal carcinoma in vivo is dependent on beta-catenin protein dysregulation, but not k-ras mutation.
Wong NA; Morris RG; McCondochie A; Bader S; Jodrell DI; Harrison DJ
J Pathol; 2002 May; 197(1):128-35. PubMed ID: 12081197
[TBL] [Abstract][Full Text] [Related]
23. Significance of aberrant (cytoplasmic/nuclear) expression of beta-catenin in pancreatoblastoma.
Tanaka Y; Kato K; Notohara K; Nakatani Y; Miyake T; Ijiri R; Nishimata S; Ishida Y; Kigasawa H; Ohama Y; Tsukayama C; Kobayashi Y; Horie H
J Pathol; 2003 Feb; 199(2):185-90. PubMed ID: 12533831
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous deregulation of p16 and cyclin D1 genes in pancreatic ductal adenocarcinoma: a combined immunohistochemistry and image analysis study based on tissue microarrays.
Tsiambas E; Karameris A; Gourgiotis S; Salemis N; Athanassiou AE; Karakitsos P; Papalois A; Merikas E; Kosmidis P; Patsouris E
J BUON; 2007; 12(2):261-7. PubMed ID: 17600882
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma.
Greer RO; Said S; Shroyer KR; Marileila VG; Weed SA
Oral Oncol; 2007 Sep; 43(8):735-41. PubMed ID: 17113340
[TBL] [Abstract][Full Text] [Related]
26. A comparative analysis of FISH, RT-PCR, PCR, and immunohistochemistry for the diagnosis of mantle cell lymphomas.
Belaud-Rotureau MA; Parrens M; Dubus P; Garroste JC; de Mascarel A; Merlio JP
Mod Pathol; 2002 May; 15(5):517-25. PubMed ID: 12011256
[TBL] [Abstract][Full Text] [Related]
27. Expression and subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in epithelial ovarian cancer.
Hurteau JA; Allison BM; Brutkiewicz SA; Goebl MG; Heilman DK; Bigsby RM; Harrington MA
Gynecol Oncol; 2001 Nov; 83(2):292-8. PubMed ID: 11606087
[TBL] [Abstract][Full Text] [Related]
28. p27 and cyclin D1 abnormalities in uterine papillary serous carcinoma.
Schmitz MJ; Hendricks DT; Farley J; Taylor RR; Geradts J; Rose GS; Birrer MJ
Gynecol Oncol; 2000 Jun; 77(3):439-45. PubMed ID: 10831356
[TBL] [Abstract][Full Text] [Related]
29. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas.
Rodrigo JP; García-Carracedo D; García LA; Menéndez S; Allonca E; González MV; Fresno MF; Suárez C; García-Pedrero JM
J Pathol; 2009 Mar; 217(4):516-23. PubMed ID: 18991334
[TBL] [Abstract][Full Text] [Related]
30. Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan.
Huang WS; Tang R; Lin PY; Changchien CR; Chen JS; Chiang JM; Yeh CY; Wang JY; Hsieh LL
Dis Colon Rectum; 2006 May; 49(5):602-8. PubMed ID: 16552496
[TBL] [Abstract][Full Text] [Related]
31. [Expression and Significance of BP1 Gene and Cyclin D1 Gene in Breast Cancer].
Song YC; Fu SD; Wen XP; Ma ZH; Dang CX
Ai Zheng; 2007 Jul; 26(7):709-14. PubMed ID: 17626745
[TBL] [Abstract][Full Text] [Related]
32. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct.
Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of cyclin D1 in epithelial ovarian cancers.
Worsley SD; Ponder BA; Davies BR
Gynecol Oncol; 1997 Feb; 64(2):189-95. PubMed ID: 9038263
[TBL] [Abstract][Full Text] [Related]
34. beta-catenin nuclear expression correlates with cyclin D1 overexpression in sporadic desmoid tumours.
Saito T; Oda Y; Tanaka K; Matsuda S; Tamiya S; Iwamoto Y; Tsuneyoshi M
J Pathol; 2001 Sep; 195(2):222-8. PubMed ID: 11592102
[TBL] [Abstract][Full Text] [Related]
35. Cyclin E mRNA overexpression in epithelial ovarian cancers: inverse correlation with p53 protein accumulation.
Sawasaki T; Shigemasa K; Shiroyama Y; Kusuda T; Fujii T; Parmley TH; O'Brien TJ; Ohama K
J Soc Gynecol Investig; 2001; 8(3):179-85. PubMed ID: 11390254
[TBL] [Abstract][Full Text] [Related]
36. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
[TBL] [Abstract][Full Text] [Related]
37. Epidermal growth factor receptor expression in serous ovarian carcinoma: an immunohistochemical study with galectin-3 and cyclin D1 and outcome.
Brustmann H
Int J Gynecol Pathol; 2008 Jul; 27(3):380-9. PubMed ID: 18580315
[TBL] [Abstract][Full Text] [Related]
38. Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome.
Bondi J; Husdal A; Bukholm G; Nesland JM; Bakka A; Bukholm IR
J Clin Pathol; 2005 May; 58(5):509-14. PubMed ID: 15858123
[TBL] [Abstract][Full Text] [Related]
39. Cyclin D1 protein and CCND1 gene expression in colorectal cancer.
Balcerczak E; Pasz-Walczak G; Kumor P; Panczyk M; Kordek R; Wierzbicki R; Mirowski M
Eur J Surg Oncol; 2005 Sep; 31(7):721-6. PubMed ID: 15993030
[TBL] [Abstract][Full Text] [Related]
40. In situ hybridization and reverse transcription-polymerase chain reaction for cyclin D1 mRNA in the diagnosis of mantle cell lymphoma in paraffin-embedded tissues.
Athanasiou E; Kotoula V; Hytiroglou P; Kouidou S; Kaloutsi V; Papadimitriou CS
Mod Pathol; 2001 Feb; 14(2):62-71. PubMed ID: 11235907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
